Figure 4From: Effect of histamine-2-receptor antagonists versus sucralfate on stress ulcer prophylaxis in mechanically ventilated patients: a meta-analysis of 10 randomized controlled trialsIntensive care unit mortality of histamine-2-receptor antagonists (H 2 RA) versus sucralfate. Fixed-effects model of odds ratio (95% confidence interval, or CI) of intensive care unit mortality associated with H2RA compared with sucralfate is shown.Back to article page